Gujarat Meditech Financials

BSE: 524754

₹4.20

₹0.20 (5.00%)

As on 06-Jan-2020IST

Market cap

₹2 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Operating Revenue	0.68	0.75	0.44	0.49	0.03	0.03
Total Income	0.70	0.75	0.44	0.49	0.03	0.03
Total Expenditure	0.70	0.75	0.44	0.49	0.03	0.03
EBITDA	-0.02	0.00	0.00	0.00	0.00	0.00
Depreciation	--	--	--	--	--	--
EBIT	-0.02	0.00	0.00	0.00	0.00	0.00
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	0.02	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.00	0.00	0.00	0.00	0.00	0.00
Provision for Tax	--	--	0.00	0.00	--	0.00
Profit after Tax	0.00	0.00	0.00	0.00	0.00	0.00

Liabilities (₹ Cr)	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Shareholder's Funds	4.34	4.34	4.34	4.34	4.34	4.34
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.23	0.24	0.24	0.24	0.24	0.35
Current Liabilities	0.96	1.21	1.10	0.65	0.00	0.00
Total Liabilities	5.53	5.79	5.67	5.22	4.57	4.69

Assets (₹ Cr)	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Non-Current Assets	3.60	4.78	4.63	4.61	4.50	4.60
Current Assets	0.90	1.01	1.04	0.61	0.07	0.09
Total Assets	5.53	5.79	5.67	5.22	4.57	4.69
Total Debt*	--	0.46	0.46	0.41	0.23	0.35
Net Current Assets	-0.06	-0.20	-0.06	-0.04	0.07	0.09
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Cash From Operating Activities	--	0.04	0.00	0.05	0.01	0.00
Cash Flow from Investing Activities	--	--	--	--	--	0.00
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	0.04	0.00	0.05	0.01	0.00

Financials Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Adjusted EPS (₹)	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	--	0.00	0.00	0.00	0.00	0.00
Adjusted Book Value (₹)	--	10.57	10.57	10.57	10.57	10.57
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.10	0.00	0.11	0.03	0.00
Free Cash Flow per Share (₹)	--	0.10	-0.03	0.08	0.03	0.00

Profitability Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
ROCE (%)	--	0.01	0.02	0.01	0.01	0.02
ROE (%)	0.02	0.01	0.01	0.00	0.01	0.00
ROA (%)	0.02	0.01	0.01	0.00	0.01	0.00
EBIT Margin (%)	-2.35	0.08	0.17	0.06	2.08	3.29
Net Margin (%)	0.14	0.04	0.09	0.01	0.96	0.42
Cash Profit Margin (%)	--	0.04	0.09	0.01	0.96	0.42

Growth Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Revenue Growth (%)	20.28	71.62	-10.91	1,546.57	1.02	-90.69
EBIT Growth (%)	-433.33	-23.39	173.06	-56.13	-36.26	158.63
Net Profit Growth (%)	-90.91	-18.72	672.97	-82.90	129.69	107.31
EPS Growth (%)	-90.67	-16.28	800.00	-85.71	133.33	107.18
Book Value Growth (%)	--	0.01	0.01	0.00	0.01	0.00

Valuation Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Price / Earnings	--	5,441.62	4,865.12	--	6,285.71	--
Price / Book Value	0.40	0.39	0.43	0.20	0.42	0.90
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2,021.58	3,473.98	2,941.93	4,187.73	3,166.81	4,300.57
Close Price (₹)	--	4.10	4.51	2.08	4.40	9.50
High Price (₹)	--	4.63	4.63	6.75	13.74	24.15
Low Price (₹)	--	3.90	1.01	1.81	4.18	7.00
Market Cap (₹ Cr)	1.73	1.68	1.85	0.85	1.81	3.90

Solvency Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Debt to Equity	0.05	0.10	0.10	0.09	0.05	0.08
Short term debt to equity ratio	0.05	0.05	0.05	0.04	--	--
Current Ratio	0.94	0.83	0.95	0.94	138.35	157.86
Quick Ratio	0.94	0.83	0.95	0.94	138.35	157.86
Interest Coverage	--	2.19	3.86	3.77	1.87	1.19

Operating Efficiency Ratios	TTM	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Debtors to sales (%)	121.11	112.10	211.23	99.65	--	91.05
Asset Turnover	0.12	0.13	0.08	0.10	0.01	0.01
Receivable days	--	429.21	589.63	363.74	--	332.33
Inventory Days	--	1.21	--	--	--	--
Payable days	--	461.40	608.26	365.00	--	--
Cash Conversion Cycle	--	-30.98	-18.63	-1.26	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.